CLRB - Cellectar Bio readies stock offering

Cellectar Biosciences (CLRB) intends to offer and sell shares of its common stock in a public offering.Actual size, price or terms of the offering are not yet determined. Concurrently, the Company expects to sell common stock and convertible preferred stock at a public offering price, in a private placement. Oppenheimer is acting as the sole book-running manager.Shares down 22% after-hours.

For further details see:

Cellectar Bio readies stock offering